biohack.The longevity wire
LIVE WIREUpdated · scanning every 6 hours
04:11 Aging muscle may give up strength to protect its cells, mouse study finds✦04:17 Brain-only immune cell therapy cleared a deadly child brain cancer in mice✦04:14 Custom vaccines sparked immune responses in 8 of 10 ovarian cancer patients✦04:13 UK pupils kept in school one more year had lower dementia risk later✦04:10 Old mouse ovaries turned younger in young mice and produced healthy pups✦04:09 Looped RNA drug raised saliva flow in small trial for radiation dry mouth✦22:17 Gene therapy improved swallowing in all 9 patients so far, maker says✦22:16 Taurine helps keep aging inflammation in check in lab tests, study finds✦04:11 Aging muscle may give up strength to protect its cells, mouse study finds✦04:17 Brain-only immune cell therapy cleared a deadly child brain cancer in mice✦04:14 Custom vaccines sparked immune responses in 8 of 10 ovarian cancer patients✦04:13 UK pupils kept in school one more year had lower dementia risk later✦04:10 Old mouse ovaries turned younger in young mice and produced healthy pups✦04:09 Looped RNA drug raised saliva flow in small trial for radiation dry mouth✦22:17 Gene therapy improved swallowing in all 9 patients so far, maker says✦22:16 Taurine helps keep aging inflammation in check in lab tests, study finds
← All story threadsSTORY THREAD

Natera's blood test that screens for many cancers.

1 report so far. New developments are added to this thread as they happen.

  1. Oct 9, 2026
    FDA GRANTS A FASTER REVIEW TRACKFDA designation · 12 cancers

    FDA puts Natera's blood test for many cancers on a faster review track

    Natera says the FDA gave its multi-cancer screening blood test a Breakthrough Device designation. It is not an approval, and the company has published no accuracy numbers.